JESSICA JAIRALA-BERMUDEZ: Open Payments
NPI 1548603756 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,772 in 92 payments from 18 companies in 2025. Trend: 2023 $1,109 · 2024 $1,778 · 2025 $1,772
Food & beverage: $1,695Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $510 |
| ABBVIE INC. | 22 | $387 |
| Madrigal Pharmaceuticals | 11 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $122 |
| Lilly USA, LLC | 6 | $115 |
| Ardelyx, Inc. | 4 | $64 |
| Gilead Sciences, Inc. | 2 | $58 |
| Aimmune Therapeutics, Inc. | 2 | $53 |
| Intercept Pharmaceuticals, Inc. | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 4 | $49 |
Products named: TREMFYA, LINZESS, RINVOQ, REZDIFFRA, ENTYVIO, OMVOH, IBSRELA, DUPIXENT.
Industry payments across FL — which companies pay providers there.
